Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine

Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine

Abstract Background In 2007, we initiated IMPACT, a precision medicine program for patients referred for participation in early-phase clinical trials. We assessed the correlation of factors, including genomically matched therapy, with overall survival (OS). Patients and methods We performed molecula...

Full description

Bibliographic Details
Main Authors: Apostolia-Maria Tsimberidou, David S. Hong, Jennifer J. Wheler, Gerald S. Falchook, Filip Janku, Aung Naing, Siqing Fu, Sarina Piha-Paul, Carrie Cartwright, Russell R. Broaddus, Graciela M. Nogueras Gonzalez, Patrick Hwu, Razelle Kurzrock
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Journal of Hematology & Oncology
Subjects:
Personalized medicine
Phase I
Clinical trials
Targeted therapy
Genomic profiling
Precision oncology
Online Access:https://doi.org/10.1186/s13045-019-0835-1

Internet

https://doi.org/10.1186/s13045-019-0835-1

Similar Items